Browsing by Author "Karakoç, Emre"
Now showing items 1-5 of 5
-
Embryonic microenvironment suppresses YY1 and YY1-related genes in prostate cancer stem cells
Taşkıran, Ayşegül; Öktem, Gülperi; Demir, Aleyna; Oltulu, Fatih; Özçınar, Emine; Düzağaç, Fahriye; Güven, Ümmü; Karakoç, Emre; Çakır, Aslı; Ayla, Şule; Güven, Selçuk; Açıkgöz, Eda (2024)Yin yang 1 (YY1), a transcription factor, plays crucial roles in cell fate specification, differentiation, and pluripotency during embryonic development. It is also involved in tumorigenesis, drug resistance, metastasis, ... -
Genomic resources for wild populations of the house mouse, Mus musculus and its close relative Mus spretus
Harr, Bettina; Karakoç, Emre; Neme, Rafik; Teschke, Meike; Pfeifle, Christine; Pezer, Zeljka; Babiker, Hiba; Linnenbrink, Miriam; Montero, Inka; Scavetta, Rick; Abai, Mohammad Reza; Puente Molins, Marta; Schlegel, Mathias; Ulrich, Rainer G.; Altmueller, Janine; Franitza, Marek; Buentge, Anna; Kuenzel, Sven; Tautz, Diethard (Nature Publishing Group, 2016)Wild populations of the house mouse (Mus musculus) represent the raw genetic material for the classical inbred strains in biomedical research and are a major model system for evolutionary biology. We provide whole genome ... -
Identification of protein-protein interaction bridges for multiple sclerosis
Yazıcı, Gözde; Kurt Vatandaşlar, Burcu; Aydın Cantürk, İlknur; Aydınlı, Fatmagül İlayda; Arıcı Düz, Özge; Karakoç, Emre; Kerman, Bilal Ersen; Alkan, Can (Oxford University Press, 2023)Motivation: Identifying and prioritizing disease-related proteins is an important scientific problem to develop proper treatments. Network science has become an important discipline to prioritize such proteins. Multiple ... -
Integrating personalized genomics into Turkish healthcare system: A cancer-oriented pilot activity of Istanbul Northern Anatolian Public Hospitals with GLAB
Doğanay, Levent; Özdil, Kamil; Memişoğlu, Kemal; Katrinli, Şeyma; Karakoç, Emre; Nikerel, Emrah; Dinler Doğanay, Gizem (Kare Publishing, 2017)… -
Splicing variants of versican in CD133+/CD44+ prostate cancer stem cells
Ayla, Şule; Karakoç, Emre; Yozgat Byrne, Yasemin; Parlayan, Cüneyd; Keskin, İlknur; Karahüseyinoğlu, Serçin; Taşkıran, Ayşegül; Öktem, Gülperi (2024)A cancer mass is composed of a heterogeneous group of cells, a small part of which constitutes the cancer stem cells since they are less differentiated and have a high capacity to develop cancer. Versican is an extracellular ...
